Utah Medical Products (UTMD) Gross Margin (2010 - 2026)

Utah Medical Products' Gross Margin history runs 17 years deep, the most recent figure standing at 60.56% for Q1 2026.

• In Q1 2026, Gross Margin rose 353.0% year-over-year to 60.56%; the TTM figure through Mar 2026 stood at 57.94% (down 41.0% YoY), while the FY2025 annual figure was 57.12%, down 191.0% from the prior year.
• Gross Margin was 60.56% for Q1 2026 at Utah Medical Products, up from 58.2% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 63.19% in Q3 2022 to a low of 56.21% in Q2 2025.
• Historically, Gross Margin has averaged 59.45% across 5 years, with a median of 59.66% in 2024.
• The sharpest annual moves came in 2023 and 2026: Gross Margin slumped 434 bps in 2023, then surged 353 bps in 2026.
• A 5-year view of Gross Margin shows it stood at 61.34% in 2022, then fell by 6 bps to 57.55% in 2023, then climbed by 1 bps to 58.13% in 2024, then rose by 0 bps to 58.2% in 2025, then climbed by 4 bps to 60.56% in 2026.
• The last three Gross Margin figures came in at 60.56% (Q1 2026), 58.2% (Q4 2025), and 57.11% (Q3 2025), per Business Quant data.